These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1542672

  • 41. In vivo 19F MR imaging and spectroscopy for the BNCT optimization.
    Porcari P, Capuani S, D'Amore E, Lecce M, La Bella A, Fasano F, Migneco LM, Campanella R, Maraviglia B, Pastore FS.
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S365-8. PubMed ID: 19375924
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
    Hua Z, Gibson SL, Foster TH, Hilf R.
    Cancer Res; 1995 Apr 15; 55(8):1723-31. PubMed ID: 7712481
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Biopharmaceutics of boronated radiosensitizers: liposomal formulation of MnBOPP (manganese chelate of 2,4-(alpha, beta-dihydroxyethyl) deuterioporphyrin IX) and comparative toxicity in mice.
    Zhou R, Balasubramanian SV, Kahl SB, Straubinger RM.
    J Pharm Sci; 1999 Sep 15; 88(9):912-7. PubMed ID: 10479353
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
    Wang HE, Liao AH, Deng WP, Chang PF, Chen JC, Chen FD, Liu RS, Lee JS, Hwang JJ.
    J Nucl Med; 2004 Feb 15; 45(2):302-8. PubMed ID: 14960653
    [Abstract] [Full Text] [Related]

  • 51. Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.
    Wu G, Yang W, Barth RF, Kawabata S, Swindall M, Bandyopadhyaya AK, Tjarks W, Khorsandi B, Blue TE, Ferketich AK, Yang M, Christoforidis GA, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA.
    Clin Cancer Res; 2007 Feb 15; 13(4):1260-8. PubMed ID: 17317838
    [Abstract] [Full Text] [Related]

  • 52. Pharmacokinetic analysis and uptake of 18F-FBPA-Fr after ultrasound-induced blood-brain barrier disruption for potential enhancement of boron delivery for neutron capture therapy.
    Yang FY, Chang WY, Li JJ, Wang HE, Chen JC, Chang CW.
    J Nucl Med; 2014 Apr 15; 55(4):616-21. PubMed ID: 24525207
    [Abstract] [Full Text] [Related]

  • 53. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH, Barth RF, Wyzlic IM, Soloway AH, Rotaru JH.
    Anticancer Res; 1995 Apr 15; 15(5B):2033-8. PubMed ID: 8572598
    [Abstract] [Full Text] [Related]

  • 54. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy.
    Zuo CS, Prasad PV, Busse P, Tang L, Zamenhof RG.
    Med Phys; 1999 Jul 15; 26(7):1230-6. PubMed ID: 10435522
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G, Kawabata S, Nonoguchi N, Hiramatsu R, Toho T, Tanaka H, Masunaga SI, Hattori Y, Kirihata M, Ono K, Kuroiwa T, Miyatake SI.
    Radiat Oncol; 2017 Jan 23; 12(1):26. PubMed ID: 28114947
    [Abstract] [Full Text] [Related]

  • 58. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
    Bergenheim AT, Capala J, Roslin M, Henriksson R.
    J Neurooncol; 2005 Feb 23; 71(3):287-93. PubMed ID: 15735919
    [Abstract] [Full Text] [Related]

  • 59. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
    Dagrosa MA, Thomasz L, Longhino J, Perona M, Calzetta O, Blaumann H, Rebagliati RJ, Cabrini R, Kahl S, Juvenal GJ, Pisarev MA.
    Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1059-66. PubMed ID: 17967301
    [Abstract] [Full Text] [Related]

  • 60. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.
    Yang W, Barth RF, Adams DM, Ciesielski MJ, Fenstermaker RA, Shukla S, Tjarks W, Caligiuri MA.
    Cancer Res; 2002 Nov 15; 62(22):6552-8. PubMed ID: 12438250
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.